Labcorp
LH
Labcorp (LH) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $4.99
- EPS estimate
- $4.78
- EPS surprise
- +4.41%
- Revenue surprise
- +0.59%
- Revenue
- $3.7B
- Revenue estimate
- $3.7B
- Reported
- Jul 30, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $4.78 | $4.99 | +4.41% | $3.7B | SEC |
| Q1 2026 | Apr 30, 2026 | $4.11 | $4.25 | +3.42% | $3.5B | SEC |
| Q4 2025 | Feb 17, 2026 | $3.95 | $4.07 | +3.17% | $3.5B | SEC |
| Q3 2025 | Oct 28, 2025 | $4.13 | $4.18 | +1.21% | $3.6B | SEC |
| Q2 2025 | Jul 24, 2025 | $4.17 | $4.35 | +4.36% | $3.5B | SEC |
| Q1 2025 | Apr 29, 2025 | $3.74 | $3.84 | +2.63% | $3.3B | SEC |
| Q4 2024 | Feb 6, 2025 | $3.39 | $3.45 | +1.70% | $3.3B | SEC |
| Q3 2024 | Oct 24, 2024 | $3.47 | $3.50 | +0.79% | $3.3B | SEC |
| Q2 2024 | Aug 1, 2024 | $3.78 | $3.94 | +4.34% | $3.2B | SEC |
| Q1 2024 | Apr 25, 2024 | $3.48 | $3.68 | +5.61% | $3.2B | SEC |
| Q4 2023 | Feb 15, 2024 | $3.26 | $3.30 | +1.32% | $3.0B | SEC |
| Q3 2023 | Oct 26, 2023 | $3.33 | $3.38 | +1.40% | $3.1B | SEC |
| Q2 2023 | Jul 27, 2023 | $3.84 | $3.42 | −10.84% | $3.0B | SEC |
| Q1 2023 | Apr 25, 2023 | $3.40 | $3.28 | −3.44% | $3.8B | SEC |
| Q4 2022 | Feb 16, 2023 | $3.53 | $3.56 | +0.89% | $3.7B | SEC |
| Q3 2022 | Oct 27, 2022 | $4.01 | $4.02 | +0.28% | $3.6B | SEC |
| Q2 2022 | Jul 28, 2022 | $4.04 | $4.26 | +5.56% | $3.7B | SEC |
| Q1 2022 | Apr 28, 2022 | $5.13 | $5.25 | +2.24% | $3.9B | SEC |
| Q4 2021 | Feb 10, 2022 | $5.13 | $5.82 | +13.48% | $4.1B | SEC |
| Q3 2021 | Oct 28, 2021 | $4.22 | $5.86 | +38.71% | $4.1B | SEC |
Quarterly revenue
Frequently asked questions
When did Labcorp (LH) last report earnings?
Labcorp last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did LH beat earnings estimates?
Yes. Labcorp reported EPS of $4.99 for Q2 2026 against a $4.78 estimate — a 4.41% beat.
How much revenue did LH report last quarter?
Labcorp reported $3.7B in revenue for Q2 2026, against a consensus estimate of $3.7B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.